Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Matthias Matter"'
Autor:
Sofia Schaeffer, Christian Lutz, Michael Dobbie, Luigi M. Terracciano, Matthias Matter, Jürg Vosbeck, Markus H. Heim, Christine Bernsmeier
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundIdiosyncratic drug-induced liver injury (DILI) is a rare, unpredictable hepatic adverse event and the most common cause of acute liver failure in Europe and the US. Ribociclib is a potent Cyclin-dependent kinase 4 and 6 (CDK4/6)-inhibitor a
Externí odkaz:
https://doaj.org/article/89aa1a97aca843faafac9d5b4d159c2c
Autor:
Jasmin D Haslbauer, Alexandar Tzankov, Kirsten D Mertz, Nathalie Schwab, Ronny Nienhold, Raphael Twerenbold, Gregor Leibundgut, Anna K Stalder, Matthias Matter, Katharina Glatz
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 7, Iss 4, Pp 326-337 (2021)
Abstract While coronavirus disease 2019 (COVID‐19) primarily affects the respiratory tract, pathophysiological changes of the cardiovascular system remain to be elucidated. We performed a retrospective cardiopathological analysis of the heart and v
Externí odkaz:
https://doaj.org/article/f8345d09ff15480690a0201aede7cf6d
Autor:
Michail Yekelchyk, Esha Madan, Jochen Wilhelm, Kirsty R Short, António M Palma, Linbu Liao, Denise Camacho, Everlyne Nkadori, Michael T Winters, Emily S Rice, Inês Rolim, Raquel Cruz‐Duarte, Christopher J Pelham, Masaki Nagane, Kartik Gupta, Sahil Chaudhary, Thomas Braun, Raghavendra Pillappa, Mark S Parker, Thomas Menter, Matthias Matter, Jasmin Dionne Haslbauer, Markus Tolnay, Kornelia D Galior, Kristina A Matkwoskyj, Stephanie M McGregor, Laura K Muller, Emad A Rakha, Antonio Lopez‐Beltran, Ronny Drapkin, Maximilian Ackermann, Paul B Fisher, Steven R Grossman, Andrew K Godwin, Arutha Kulasinghe, Ivan Martinez, Clay B Marsh, Benjamin Tang, Max S Wicha, Kyoung Jae Won, Alexandar Tzankov, Eduardo Moreno, Rajan Gogna
Publikováno v:
EMBO Molecular Medicine, Vol 13, Iss 11, Pp n/a-n/a (2021)
Abstract Risk stratification of COVID‐19 patients is essential for pandemic management. Changes in the cell fitness marker, hFwe‐Lose, can precede the host immune response to infection, potentially making such a biomarker an earlier triage tool.
Externí odkaz:
https://doaj.org/article/f8eb078fb27a469bb4350f69d131fd6a
Autor:
Mariacarla Andreozzi, Cristina Quintavalle, David Benz, Luca Quagliata, Matthias Matter, Diego Calabrese, Nadia Tosti, Christian Ruiz, Francesca Trapani, Luigi Tornillo, Alfredo Fusco, Markus H. Heim, Charlotte K.Y. Ng, Pierlorenzo Pallante, Luigi M. Terracciano, Salvatore Piscuoglio
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 22, Iss 7, Pp 272-273 (2020)
Externí odkaz:
https://doaj.org/article/eaf23040defb41538e72cfa8b08b72b6
Autor:
Tala Shekarian, Sabrina Hogan, Tomás A. Martins, Philip Schmassmann, Alexandra Gerber, Julien Roux, Deniz Kaymak, Célia Durano, Bettina Burger, Matthias Matter, Marie-Françoise Ritz, Gregor Hutter
Background: Glioblastoma (GBM) is a lethal brain tumor without effective treatment options. The aim of this study was to characterize longitudinal tumor immune microenvironment (iTME) changes in order to find potential actionable targets to prevent G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efbcfbf47ae78b8802ad181b5c22bceb
https://doi.org/10.1101/2023.04.21.537308
https://doi.org/10.1101/2023.04.21.537308
Autor:
Adrian F. Ochsenbein, Dorothee von Laer, Tsanan Giroglou, Bruno Eschli, Sabine Mumprecht, Daniel D. Pinschewer, Viktor Pavelic, Matthias Matter
The effect of cancer immunotherapy on the endogenous immune response against tumors is largely unknown. Therefore, we studied immune responses against murine tumors expressing the glycoprotein (GP) and/or nucleoprotein of lymphocytic choriomeningitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d59691124c9ed8697ae6aca516bf77d
https://doi.org/10.1158/0008-5472.c.6495833
https://doi.org/10.1158/0008-5472.c.6495833
Autor:
Adrian F. Ochsenbein, Dorothee von Laer, Tsanan Giroglou, Bruno Eschli, Sabine Mumprecht, Daniel D. Pinschewer, Viktor Pavelic, Matthias Matter
Supplementary Legends 1-2 from Decreased Tumor Surveillance after Adoptive T-Cell Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36a8b4e399b6cb8090b39c41058bfd60
https://doi.org/10.1158/0008-5472.22368146.v1
https://doi.org/10.1158/0008-5472.22368146.v1
Autor:
Adrian F. Ochsenbein, Dorothee von Laer, Tsanan Giroglou, Bruno Eschli, Sabine Mumprecht, Daniel D. Pinschewer, Viktor Pavelic, Matthias Matter
Supplementary Figure 1 from Decreased Tumor Surveillance after Adoptive T-Cell Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::149dde859ae25bab816b8d90b0a1cc54
https://doi.org/10.1158/0008-5472.22368152
https://doi.org/10.1158/0008-5472.22368152
Autor:
Adrian F. Ochsenbein, Dorothee von Laer, Tsanan Giroglou, Bruno Eschli, Sabine Mumprecht, Daniel D. Pinschewer, Viktor Pavelic, Matthias Matter
Supplementary Figure 2 from Decreased Tumor Surveillance after Adoptive T-Cell Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27a7e2942c1c4668b67acc751a70f6dc
https://doi.org/10.1158/0008-5472.22368149
https://doi.org/10.1158/0008-5472.22368149
Autor:
Vanessa Escher-Michlig, Tatjana Vlajnic, Luca Roma, Mattia Marinucci, Salvatore Piscuoglio, Matthias Matter, Martin Haug, Walter P. Weber, Simone Muenst
Background Cylindroma of the breast is a rare benign neoplasm. Since its first description in 2001, 18 cases have been reported in the literature. Methods and Results We report another case of this rare tumor in a 60-year-old woman with demonstration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36176e51e9b9b53ccd068ea1b8cf1e37
https://doi.org/10.21203/rs.3.rs-2696872/v1
https://doi.org/10.21203/rs.3.rs-2696872/v1